171 related articles for article (PubMed ID: 23070119)
1. Novel protein transduction domain mimics as nonviral delivery vectors for siRNA targeting NOTCH1 in primary human T cells.
Tezgel AÖ; Gonzalez-Perez G; Telfer JC; Osborne BA; Minter LM; Tew GN
Mol Ther; 2013 Jan; 21(1):201-9. PubMed ID: 23070119
[TBL] [Abstract][Full Text] [Related]
2. Development of Guanidinium-Rich Protein Mimics for Efficient siRNA Delivery into Human T Cells.
deRonde BM; Torres JA; Minter LM; Tew GN
Biomacromolecules; 2015 Oct; 16(10):3172-9. PubMed ID: 26324222
[TBL] [Abstract][Full Text] [Related]
3. Optimal Hydrophobicity in Ring-Opening Metathesis Polymerization-Based Protein Mimics Required for siRNA Internalization.
deRonde BM; Posey ND; Otter R; Caffrey LM; Minter LM; Tew GN
Biomacromolecules; 2016 Jun; 17(6):1969-77. PubMed ID: 27103189
[TBL] [Abstract][Full Text] [Related]
4. Mapping Optimal Charge Density and Length of ROMP-Based PTDMs for siRNA Internalization.
Caffrey LM; deRonde BM; Minter LM; Tew GN
Biomacromolecules; 2016 Oct; 17(10):3205-3212. PubMed ID: 27599388
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticulate nonviral agent for the effective delivery of pDNA and siRNA to differentiated cells and primary human T lymphocytes.
Schallon A; Synatschke CV; Jérôme V; Müller AH; Freitag R
Biomacromolecules; 2012 Nov; 13(11):3463-74. PubMed ID: 23020076
[TBL] [Abstract][Full Text] [Related]
6. Effective gene suppression using small interfering RNA in hard-to-transfect human T cells.
Yin J; Ma Z; Selliah N; Shivers DK; Cron RQ; Finkel TH
J Immunol Methods; 2006 May; 312(1-2):1-11. PubMed ID: 16603179
[TBL] [Abstract][Full Text] [Related]
7. Efficient delivery of Notch1 siRNA to SKOV3 cells by cationic cholesterol derivative-based liposome.
Zhao YC; Zhang L; Feng SS; Hong L; Zheng HL; Chen LL; Zheng XL; Ye YQ; Zhao MD; Wang WX; Zheng CH
Int J Nanomedicine; 2016; 11():5485-5496. PubMed ID: 27799771
[TBL] [Abstract][Full Text] [Related]
8. Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells.
Zou J; Li P; Lu F; Liu N; Dai J; Ye J; Qu X; Sun X; Ma D; Park J; Ji C
J Hematol Oncol; 2013 Jan; 6():3. PubMed ID: 23289374
[TBL] [Abstract][Full Text] [Related]
9. siRNA stabilization prolongs gene knockdown in primary T lymphocytes.
Mantei A; Rutz S; Janke M; Kirchhoff D; Jung U; Patzel V; Vogel U; Rudel T; Andreou I; Weber M; Scheffold A
Eur J Immunol; 2008 Sep; 38(9):2616-25. PubMed ID: 18792414
[TBL] [Abstract][Full Text] [Related]
10. PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth.
Su Y; Yu L; Liu N; Guo Z; Wang G; Zheng J; Wei M; Wang H; Yang AG; Qin W; Wen W
Cancer Lett; 2013 Sep; 338(2):282-91. PubMed ID: 23752065
[TBL] [Abstract][Full Text] [Related]
11. NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cells.
Okuhashi Y; Itoh M; Nara N; Tohda S
Anticancer Res; 2013 Oct; 33(10):4293-8. PubMed ID: 24122995
[TBL] [Abstract][Full Text] [Related]
12. [Effect of CRE-dependent RNA interference targeting Notch1 on proliferation of cervical cancer cell line HeLa].
Yu H; Huang SL; Zhao XP; Lu J; Qian GX; Ge SF
Ai Zheng; 2007 Feb; 26(2):148-53. PubMed ID: 17298743
[TBL] [Abstract][Full Text] [Related]
13. Notch1 targeting siRNA delivery nanoparticles for rheumatoid arthritis therapy.
Kim MJ; Park JS; Lee SJ; Jang J; Park JS; Back SH; Bahn G; Park JH; Kang YM; Kim SH; Kwon IC; Jo DG; Kim K
J Control Release; 2015 Oct; 216():140-8. PubMed ID: 26282098
[TBL] [Abstract][Full Text] [Related]
14. A Method for Targeted Nonviral siRNA Delivery in Cancer and Inflammatory Diseases.
Kandil R; Xie Y; Mehta A; Merkel O
Methods Mol Biol; 2020; 2059():155-166. PubMed ID: 31435920
[TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA (siRNA)-mediated knockdown of Notch1 suppresses tumor growth and enhances the effect of IL-2 immunotherapy in malignant melanoma.
Yang Z; Qi Y; Lu C; Zhang J; Luo R; Kang S
J BUON; 2015; 20(6):1553-64. PubMed ID: 26854453
[TBL] [Abstract][Full Text] [Related]
16. Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein.
Eguchi A; Meade BR; Chang YC; Fredrickson CT; Willert K; Puri N; Dowdy SF
Nat Biotechnol; 2009 Jun; 27(6):567-71. PubMed ID: 19448630
[TBL] [Abstract][Full Text] [Related]
17. Synthetic Protein Mimics for Functional Protein Delivery.
Tezgel AÖ; Jacobs P; Backlund CM; Telfer JC; Tew GN
Biomacromolecules; 2017 Mar; 18(3):819-825. PubMed ID: 28165726
[TBL] [Abstract][Full Text] [Related]
18. Selective suppression of Notch1 inhibits proliferation of renal cell carcinoma cells through JNK/p38 pathway.
Wu K; Hu L; Hou J
Oncol Rep; 2016 May; 35(5):2795-800. PubMed ID: 26986634
[TBL] [Abstract][Full Text] [Related]
19. T cell-specific siRNA delivery using antibody-conjugated chitosan nanoparticles.
Lee J; Yun KS; Choi CS; Shin SH; Ban HS; Rhim T; Lee SK; Lee KY
Bioconjug Chem; 2012 Jun; 23(6):1174-80. PubMed ID: 22607555
[TBL] [Abstract][Full Text] [Related]
20. Early-stage development of novel cyclodextrin-siRNA nanocomplexes allows for successful postnebulization transfection of bronchial epithelial cells.
Hibbitts A; O'Mahony AM; Forde E; Nolan L; Ogier J; Desgranges S; Darcy R; MacLoughlin R; O'Driscoll CM; Cryan SA
J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):466-77. PubMed ID: 24665866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
